Articles

  • Dec 4, 2023 | onlinelibrary.wiley.com | Sarah Bamford |Robert Jones |Wil Gardner |Benjamin W. Muir

    1 Introduction Windows are generally considered the least energy efficient component of buildings, as they do not block the sun's heat entering a building, or prevent the warmth generated inside from being lost.[1] To combat these issues, low-E coatings can be sputtered onto the surface of architectural glass as a cost-efficient way to improve its energy efficiency.[1-3] The emissivity of an object is a ratio that compares the heat it emits to that of a blackbody, which has an emissivity of...

  • Sep 21, 2023 | mlo-online.com | Laura Dalton |Robert Jones |Jackie Weiss

    Sadly, the current reality of healthcare for millions of people in the United States looks bleak. In 2022, there were 30 million Americans who had no health insurance, and more than 85 million were enrolled in Medicaid.1,2 Lack of insurance or finding clinicians that accept subsidized coverage can dissuade patients from receiving medical care. People of color and diverse backgrounds have faced longstanding disparities in health coverage that contribute to inequalities in health.

  • Sep 6, 2023 | mlo-online.com | Robert Jones |Jackie Weiss

    TherageniX and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery. TherageniX will initially focus on orthopedic applications, with the aim of improving the outcomes for patients undergoing bone grafting procedures.

  • Aug 24, 2023 | mlo-online.com | Robert Jones

    In the fall of 2022, the United States reached a historic and critical milestone — its organ donation system surpassed 1 million organ transplants, more than any other country in the world.1 Each of these 1 million organs represents an individual living with a condition that requires exceptional care. These patients must endure ongoing post-transplant monitoring, anti-rejection medications, and other therapies.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →